Latest / The Dokkcast / From Injury to Holistic Health Leadership with Brad Clifford
Transcript
- 0:04Nara: So Brad, thank you so much for joining me today on this You Dokkcast. Really wonderful to have you here. Tell me a little bit about your background as to how you came to be in The UK and a little bit around your approach to health, fitness, wellness, just a general overview.
- 0:22Brad: Sure. So, I mean, coming to The UK had a lot to do with my wife,
- 0:26Nara: who's English.
- 0:27Brad: So that's, I heavily weighted on that side, but I've been an athlete my whole life. And so I was a collegiate American football player
- 0:38Nara: in
- 0:39Brad: university. My exposure to the healthcare space came from performance type, performance medicine for the most part, physios, performance training, things like that. But until I got exposed to actual clinicians, it took me getting myself injured. And during that process of injury and surgeries, I was exposed to that world. My first exposure was I had a psoas abscess that no one knew how I got.
- 1:13I lived in Mexico for two years, was hypothesized that, you know, very got something, unusual.
- 1:19Nara: Very And it would have been difficult to diagnose those, not a
- 1:23Brad: Extremely,
- 1:24Nara: not- Opious.
- 1:26Brad: And how it happened was the most non ideal situation for an athlete. I had just won the starting job, I'm young in my career. We're going to play the University of Michigan. All the stars are aligning in my career for athletics. And during the week prior to prep for that, every single day, I started to have like psoas pain.
- 1:51Nara: And how old were you at this point? When were at college, right?
- 1:54Brad: I was 20, must've been 21 or 22, I believe. Okay, so
- 1:58Nara: is that second or third year of college?
- 1:59Brad: It was my Second
- 2:00Nara: year, okay.
- 2:01Brad: Or third year, sorry.
- 2:01Nara: Third year,
- 2:02Brad: third year.
- 2:03Nara: And which university were you playing for? For those who don't know, having, because collegiate football is a really
- 2:07Brad: big
- 2:07Nara: thing.
- 2:07Brad: It's a big, big, big deal in The United States. I was with the University of Utah. And I played tight end and I had secured my future with performing well, all these things, and I was so excited. But I had hip pain and psoas pain and very regular to have injuries and nags and things like that. But what ended up happening is every day for about three days straight, I couldn't extend my leg out and it got worse and worse, and had abdominal pain.
- 2:39Ultimately, we were trying to figure out what the injury was, wrap it up, take care of it, and all those things to just manage through and play.
- 2:46Nara: Probably they just thought it was a muscle We
- 2:48Brad: all did. We had hypothesized like, Hey, maybe you tore your labrum. We'll fix that at the end of the season. It's one of those.
- 2:55Nara: You'll fine. You'll
- 2:56Brad: good. We'll get you through it. But ultimately one night it got so bad, I started having a fever and I started throwing up bile.
- 3:04Nara: Oh, wow.
- 3:05Brad: And immediately, it was I think three in the morning, I had messaged our physio and the physio team and they had immediately called me in and right when I got there, mean, was
- 3:16Nara: By that point in a bad was really bad.
- 3:18Brad: Rushed me to the ER.
- 3:19Nara: At And this point you would've been septic, right?
- 3:21Brad: Yes, well, very close. And we got in and immediately had an MRI, contrast based MRI. And when I went in, I was with our physician and one of the on call orthopedic physicians. When I came out, I have had probably eight residents and four fellows in the MRI reading room. And I was looking around like, I'm young, I'm not exposed to these things.
- 3:50Do I have cancer? What's going on? It was a very quick, hey, here's where things are wrong. You've got an encapsulated sack of fluid that's, you're close to being septic. If we don't act now, you could die.
- 4:07Nara: Yeah, oh, thanks.
- 4:09Brad: Awesome. Can I play in two days? Am I okay to play? Let's talk later. We need to rush you in.
- 4:16And so immediately I got put in and they had tried to relieve some pressure. Immediately trying to pull out some some of that. Yep. Now knowing they're gonna do surgery, invasive surgery. And when they got the needle in, it just started spraying.
- 4:33It was almost a half liter. Oh, It was so much. And just that relief of 100 cc's being pulled out twice. I'm like, Oh, you got it all out. They're like, No.
- 4:44Nara: No, they weren't there. No, No, weren't
- 4:46Brad: there. So immediately got rushed in, had a PICC line for two weeks. I had a nine month recovery. But just going through that process, they ended up putting me in a journal that my case was very unique, they don't know how I got it. It's really unusual.
- 4:59Just for two reasons, they didn't know how I got it. And also the two physicians that operated on me, they did a psoas muscle sparing technique. Going they had to bring me down to reality of you might not be able to run again.
- 5:18Nara: That is a big I
- 5:20Brad: mean, run again. I'm supposed to be playing on one I'm of the biggest going to the NFL, what are you talking about? So that was hard to hear. But I had incredible physicians that operated on me and spared a lot of my anatomy to access that and get everything out, obviously. But so I was sparing and for the most part, musculature sparing to where I could play again.
- 5:46It was a nine month recovery. But in that process, I got really close to orthopedic surgeons, got really close to my orthopedic surgeon that was our team doctor, and started understanding what their life was like, what you do every day and how do people support these people? Didn't even know there was a whole industry that supported these people. When you're young, you don't really get all the ins and outs of what's happening. And so unfortunately for me, I had more injuries.
- 6:13And then I had a shoulder surgery my senior year, which took my dreams of the NFL kind of away from me. But going through that process, I had one of my high school teammates that was randomly a part of the surgical crew. And I'm like, what are you doing here? Hey, I'm a representative of one of the companies that works with doctor, his name's Doctor. Grice, he wouldn't mind me talking about him.
- 6:37I work with Doctor. Grice all the time and I'm like, and why? What do you do?
- 6:41Nara: What do you do?
- 6:41Brad: And so that was kind of the spark of like, there's this whole industry, I didn't myself, I thought I maybe would want it to be a dentist. I loved anatomy. I was obsessed with how the body worked and things like that. But as I had my own injuries and getting into the process of interventional type surgical procedures and things like that, I just was exposed to this whole world of, okay, are people that support that aren't just physicians, aren't just nurses, and what does that look like? And so I graduated college and then I ended up getting into that supportive world.
- 7:16Nara: And
- 7:17Brad: so started with orthopedics and did seven and a half years with a company called Stryker that
- 7:22Nara: I'm sure Oh, Stryker, yes, very
- 7:23Brad: much Spent a lot of time doing regenerative orthopedics and then sports medicine. So a lot of ACL surgeries, lot of femoral acetabular impingement surgeries, joint specific work, shoulders, knees, hips. And what did
- 7:38Nara: you do with Stryker? What was your role with them and how did you work with them?
- 7:41Brad: Yeah, so I managed a couple state area for the company in that specific segment of sports medicine. And I had a team of clinical support that we supported all these physicians. So that was the start of my career. I was like, okay, you can do a lot of work. As you know, in surgical suite, in the theater itself, it's not just the physician, there's a harmonious team supporting the whole process.
- 8:09And I got really good at hip based surgery and had litany of tools that were very supportive to physicians in that surgery at the time that were highly innovative, doing like a minimally invasive hip procedure for FAI was just kind of coming around, like how do you do it? Do you leave the capsule open? Do you close the capsule? All these things. And that whole process of going, okay, outside of the box thinking of what consensus based procedural surgery, like what that looks like, you can think outside the box and innovate and improve the process itself and not be something crazy.
- 8:54Nara: And actually these companies like Stryker, Medtronic, some of them, they actually are always trying to do things in a different and a better way.
- 9:02Brad: 100%.
- 9:03Nara: So they tend to be very good companies for innovation, very obviously sort of hardware focused for the most part. Yes. But they do tend to do that, right?
- 9:12Brad: And they're trying to push the envelope because the origin of what's being done is always, for the most part, the right direction, but it's how do we evolve to make this a more objectively better thing? And so that seed was early in my career of how do we make things better and improve either the workflow, is this better for the patient? Is this better for the physician? All those things. So I always challenged the consensus.
- 9:48Yep, yep. I always early. And, you know, I had a successful early career doing that and building teams that thought like that. And we did a lot of good work for the company of Stryker. Yeah.
- 10:00But that led to me kind of going beyond that and kind of leading clinical teams. And so that took me to another company, Merit Medical. And I worked with them in interventional radiology for some time in leadership capacity, expanding targeted therapies like embolic and targeted cancer based procedures for uterine fibroids and other types of localized cancers where you're delivering embolic to occlude systems. And even that way of thinking was pushing the envelope. We did some procedures with VCF and patients who had horrible kyphotic backs.
- 10:47How do we, an 80 year old woman who's just completely kyphotic, how do we relieve pain and give her life back? And things like that. So we had consensus there that we were always trying to push the envelope a
- 11:00Nara: little That's interesting, right? Because Stryker is sort of more around medical technologies and devices and hardware to some degree. Yes. And then you're shifting and using that knowledge and going to the next bit, which is very much around radiology and again, interventional to some degree. And by the way, there's a really interesting bit going around AI in radiology Yes, at the
- 11:19Brad: oh my goodness.
- 11:19Nara: We can come back to as well, right? Yes. But yes, they're very complimentary, but different skill sets.
- 11:26Brad: So that, but that seed continued on, but the way in which I was trying to, because I was always thinking in the supportive role to a physician. Physicians are incredibly talented superheroes at getting specifically focused on a key area and becoming the best in the world at
- 11:46Nara: those But key
- 11:48Brad: what I always found from what my superpower was going, I'm never gonna be the hyper focused expert in this unique avenue, but what I am gonna do is help open up the vision of increasing the way that we can either collaborate with this specialty or improve the things around it.
- 12:09Nara: It's a very holistic approach, right? Looking at the whole, not just process, and at the end of it is there's a human, right?
- 12:16Brad: Correct. Yeah. So that was kind of my superpower is I could see it from 30,000 I could go into the weeds enough to translate, communicate, maybe even persuade even on those weeds. But I had the ability to think from a 30,000 foot view of what are they missing that could be supportive to their process. And that stayed with me my whole career.
- 12:36But those are all, that's how I train people on my teams to think like that too. So that time in interventional radiology exposed me just to interconnectedness, very aware of how organ systems were so heavily interconnected. I was focused on joint specific for so long, but then I got into the interconnectedness of how the body actually functioned.
- 13:01Nara: And probably a little bit around aging and
- 13:02Brad: oncology And
- 13:03Nara: as well,
- 13:04Brad: how people were developing, like what did these people with these disease states, what were, outside of here are all the symptomatic situations, how are we treating all these issues, but what are the commonalities of these patient types? What are all these things beyond what, because the physician is just very here, and now I wanna get them in their best state moving forward. I wanted to be like, well, what are the patterns here? What are the things twenty years before this that were going on? And so that was always in the back of my mind.
- 13:36I, at that time, started having my own health problems.
- 13:39Nara: Okay.
- 13:40Brad: Here I was, a person who was very educated on exercise and nutrition from being an athlete. I knew all the things I needed
- 13:49Nara: thoughts, knew about physiotherapy.
- 13:50Brad: Know all those things.
- 13:51Nara: Yep.
- 13:51Brad: I'm very accustomed to doing them, but I was having my own health challenges. And the things that worked in the past were not working. And so I went down that in my very late twenties and early thirties down that rabbit hole of, okay, why am I metabolically not the same?
- 14:10Nara: Mhmm.
- 14:10Brad: Why am I
- 14:11Nara: What's different?
- 14:12Brad: Yeah. What what is what what I robbing Peter to pay Paul for right now? Mhmm. The big slap in my face was I was traveling a lot and I was very stressful type of career. I started having panic attacks.
- 14:27And I'd wake up in the night and I'd have 3AM, I'd be like on all fours. And ultimately my wife was like, You need to figure this out.
- 14:35Nara: This is not good.
- 14:36Brad: This is not good.
- 14:37Nara: This is not good.
- 14:38Brad: And so I did. And so I started going down those rabbit holes. I transitioned around that time to work for another company in genomic based breast cancer. So I continued down that kind of cancer route in those disease states. And what was really interesting is my mother was a breast cancer, not a survivor at the time, but was going through it, ultimately became a breast cancer survivor and she's still very healthy right now.
- 15:03But I had a vested interest in figuring this out and what we could do, which was really incredible. It was again, not consensus or societally accepted types of way of treating breast cancer or working with breast cancer. But these assays and what we were able to do is to take a biopsy of the cancer itself and deduce what type of driven force that cancer was and what subtype. And then
- 15:31Nara: Which is actually now very, very exciting and much more common But
- 15:35Brad: at at the the time, oh my goodness, the amount of oncologists that I spoke with would be like, when this is fully adopted, I'll do it. Or our health system doesn't adopt this technology, so I'm doing it my way. What was really frustrating to hear though in having my mother go through this too is if you could take this, if you could leverage these types of tools and use them in part of the treatment algorithm, you could potentially avoid the need of radiation, chemotherapy for certain subtypes for these women. And what woman would not want to know that, hey, radiation is not gonna benefit my treatment. I don't have to go through it.
- 16:17I feel like one hundred percent of women I've would had these wanna know that information and have that ability to make that decision with their treating physician. So it always frustrated me. It frustrated me this concept in The United States that insurance drove so much of this power, the insurance machine. My personal opinions, I'm vocalizing my personal opinions, I have no problem being on record saying this, is that the problems in The US healthcare system, they're not coming from the physicians. They're not coming from the groups of physicians that are trying to do good work.
- 16:51Those are the superheroes in the system. The problems are coming from the insurance systems that are dictating what those physicians can do and what they cannot do. And it's been a huge problem for thirty years plus. And I got sick of it. And that was kind of my straw that broke the camel's back for me is I got so sick of seeing these women having these tools that could do the thing and when they got breast cancer.
- 17:18And these physicians that were so scared, some of them, most of them, to leverage some of these newer technologies that they're gonna wait ten maybe years before And they'll do so that was very frustrating to me. And then going back to kind of what I was talking about in the beginning is that seed planet of pushing the envelope.
- 17:37Nara: Yep. Getting to the prevention side of
- 17:40Brad: I things as well, was just, why aren't we doing this? And then so later I would have closer friends and I'd say, the ones that believed in it.
- 17:47Nara: Yep.
- 17:48Brad: And all the science, the scientific team that is behind it. I'd have these side conversations and go, now this is so incredible for breast cancer, but why aren't we leveraging this from a preventative standpoint? Why aren't we looking at things in perspective of what are my individual situations that I should be aware of, that I should be working on before they become problems if I can. And consensusly is, well, will never pay for that. There's no system for this.
- 18:19Who's gonna do it? And so I was like, what? And so I went down my own rabbit holes and I started going like a personal thing. So with the panic attacks, I had gotten on antidepressants and SSRIs in my early twenties to deal with some of the stress that I had. I had heavy anxiety.
- 18:39And then come full circle, I had the panic attacks, I got on them again. And I had terrible experiences with it. And didn't feel great, didn't feel like myself.
- 18:50Nara: It was meant to be helping you and you were not.
- 18:52Brad: They're just not, they're masking, but they're not helping. So every time I thought I would get off them, they were really tough But to get the second time I'd go around, I had invested heavily into understanding my genomic up. Okay. And how does my neurochemistry function biochemically for me Feeding, yeah. And pharmacogenomics and all those aspects of why do I respond to this like this?
- 19:19And that's interesting. I shouldn't have even taken that medication to begin with because I don't genetically respond well to that. But beyond that, what drives my anxiety? I have a heavy intolerance for caffeine. I have all these other hyper drivers on my dopamine receptors by just natural substances of food and the vitamins that I was taking, and I shouldn't have.
- 19:43And I started going down these rabbit holes. And over a period of like four months, I had deliberately intentionally relieved 90%. And this is not just like a claim for everybody because everybody is different. But for me, 90% of my anxiety driven issues, along with just, I had to metabolically get myself back in check. But going through that process was like this huge awakening of like, oh my goodness, no one really dedicates time.
- 20:12And the more research I did, there was just subsets of functional medicine people that were doing it, but they didn't have the clinical supportive structure to lean on clinical-
- 20:23Nara: Input and data Yes, to some Yeah, yeah.
- 20:27Brad: It was just so functional without any type of clinical backing. And so I started doing this on my spare time with family and friends and kind of supporting them through these particular journeys. And then at the time, peptide therapy was out and I was getting really deep into those biological mechanistic properties and how they were coming. This was pre semiglucide even made available. And so many of my own things that I was looking, trying to understand and apply, but I felt like I was fixing my own problems.
- 21:02And so I started working with my original co founder to go through all these things and going, diagnostically, what are the key areas that we need to focus on? If we could build something that was reproducible for every person for the most part to go through a process and have enough preventative tools given to them diagnostically to where they would be aware of if they were born yesterday, what are their problems? If they were looking now, what are their major problems that they should be aware of? And then for the future, how do they prevent as much as possible these things? So we thought through multiple different angles.
- 21:38We started talking openly about this, in my opinion, honestly about these kind of clinical realms that we focus on, which is we felt like, hey, when you go to a GP or you go to a family practitioner, when they draw your blood to do a yearly physical, that is not bad, but it's incomplete. And why it's incomplete is because biologically, there's so much change in the three sixty four days outside of that one day that they're looking at you.
- 22:12Nara: Just snapshot in time.
- 22:13Brad: That it's just one snapshot. And so how do we actually look at this where we're measuring and how can we get as close to matching most of the biology as possible? And ultimately we felt like every three months we're kind of matching that ninety to one hundred eighty day window of most major biological processes that are signaling that we could go snapshot, snapshot, snapshot, snapshot, and then have a great idea of where Of
- 22:43Nara: those the picture, right?
- 22:44Brad: Here's our picture and it's becoming more clear. We felt like that was foundational for population based medicine. Problem was access to those labs was always tough. And then two, we felt like, we didn't wanna be dishonest and say, Hey, a forty biomarker panel is complete.
- 23:04Nara: Yep.
- 23:05Brad: And when we started to do that, we had people that were really excited about this new thing. But at the time we weren't prepared for it. A lot of venture backed companies came into play and started saying the same thing that the family practitioner insurance based model kind of replicated, which is, hey, do a 100 biomarkers one time a year and get on the subscription thing. And it made our message get drowned a little bit and it was frustrating.
- 23:32Nara: It's a crowded market, right?
- 23:34Brad: Super crowded.
- 23:35Nara: And it's very difficult to get that noise to signal ratio and to get trustworthy science backed evidence as to why you should do one or the other. It's very difficult to get above that noise, right? And say, yes, doing it once a year is fine, but that's all it is, right? Correct. You're like probably for the last two or three months, but how has this panned out over the last year?
- 23:59How does that reflect the rest of you?
- 24:01Brad: Exactly.
- 24:02Nara: So
- 24:04Brad: it became a little bit tougher, but we had members that coming in to work with us and starting to understand what our message trying to build on, which is there's so much nuance to every individual. And so we're just trying to capture a framework and a system that allowed the nuance to get like a really cleaner picture for you to get painted.
- 24:26Nara: Cause that's what people want, don't they? They probably come to you and say, actually, I want to understand health better generally speaking, but I particularly want to know where I'm at.
- 24:37Brad: Where do I fit
- 24:38Nara: in Where do I fit
- 24:38Brad: in this?
- 24:39Nara: And what are the bits that actually, this is how I feel now and I definitely wanna feel better. Help me with that. But also I wanna be the best I can be health wise in five years, ten years, twenty years, or however long I have. That's bit people are really searching for at the minute.
- 24:56Brad: You nailed it. That's really what it is. And so we were like, okay, foundationally, we're not gonna change our tune. We're not gonna buy in. We're not gonna fall to what everyone else is saying because we don't believe in it.
- 25:08Nara: That's false.
- 25:08Brad: Yeah. And what we're gonna try to help people understand, and we call our membership foundations at that level for a reason, that foundationally, this is where you clinically should start.
- 25:19Nara: Yep.
- 25:20Brad: Everyone. You should have a clinical baseline of your snapshots that are measured against each other to have a true picture of what's going on so that you can catch some things that a specialist may be able to help you if there's truly, you know, need
- 25:33Nara: from that.
- 25:34Brad: But we're still in population based medicine. Even with that, we're still relying on all of the clinical data versus population groups. So what the intention of Elevation was to go from population based medicine as a framework, but hyper individualized on that end of one type medicine approach. So we started going, okay, foundationally, this is where everyone should start. We'll meet everyone where they are as much as we can.
- 26:01There's an investment for this. Doing it like this, here you go. But we wanted to build to what we felt like was the most optimal way to do this for one person to truly understand themselves. So we then layered in, okay, if we have these snapshots and time, what is the next avenue of a multisystem approach of analysis
- 26:23Nara: Mhmm.
- 26:24Brad: That would bring more identifiers to you that would help paint a picture In
- 26:29Nara: that individuality. More individuality. Yeah.
- 26:32Brad: And the key area for us in our next membership level or next phase of doing this is the avenue and the viewpoint of epigenetics. And so the epigenetic profiling, the way that I always kind of describe it to people is a biomarker from a clinical venous draw is telling you that day for the most part, A1C is more of an average, but for the most part, what's going on right now in this time. And we can look at that. I use a financial market as an example for this. It's like day trading commodities is your blood work on the day to day.
- 27:08It's like, okay, gold is here. If I exchange here, I
- 27:11Nara: knew I'm talk about futures.
- 27:13Brad: So then you get with epigenetics, you're now looking at more of, yes, a trend line in a future kind of standpoint of things because these EBP proxies and these methylation expressive states are telling a story of how our genetics today are actually expressing themselves in areas that just blood work alone you can't pick up on. So the whole conversation of biological aging is an ongoing conversation. Again, because of my background in clinic world, I wanna push the envelope, but I need some credibility in what we're talking about. And so from the get go, it was extremely important for me to make sure that we were partnered with institutionalized partners that were working with other institutions of credibility. And so our epigenetic partner has worked with Yale, Harvard, UCLA, and done a lot of their studies with them.
- 28:11Because it was important for me to not just be like, oh, this is what Elevation thinks We wanted to be a flag raiser, but leveraging people that are actually proving the science for the most part. And so we've been partnered with one of the world leaders in this category for almost four years now and worked very intricately with them and pushing kind of where we want them to go to. But instead of just a phenotypical age of five markers that you get from a blood work and be like, Hey, I'm 20 years old instead of 40. We wanted to really tell different stories around epigenetics and give them a good, Hey, you've got nine different ways to kind of look at this. The majority of what you're seeing here is telling us this.
- 28:57And that's more credible because it's taking multiple data sets within epigenetics and telling more of an average type picture for this person. So we tend to get people that are doing really well in organ systems, but they're maybe not doing so great in inflammatory load. There are people that we can measure against group studies that UCLA has done on some of the fittest people on earth and measure you against those group. And say do perform versus that group. And we do this in different categories.
- 29:29So we can open up that lens and then look at these beyond just those clocks, if you will, of biological aging. We can then look at actual proxy markers themselves individually. There's about 120 that we look at beyond just the blood work markers and go, categorically on like cardiovascular risk, how's it showing up? That's what you will. Versus trend lines and kind of futures versus day trading of what does your LDL, APOB, and LPA look like here?
- 29:59What are our trend lines beyond that are looking like aggregate over the last six months, three years that are telling us a futures looking kind of idea on you. And then we're getting And that helps us get into what people are talking about more commonly is like a bioidentical twin. Those twin kind of studies of like, if you do this, how does this person
- 30:21Nara: start End to up being.
- 30:22Brad: End up being, yep.
- 30:24Nara: And what you're describing, actually it's very interesting because it's not only looking at sort of a lot of the blood work that we normally do, we'll measure things that are already present. So your hemoglobin count or your liver function tests or your kidney function tests, etcetera. But doing the epigenetic data with some of that methylation studies, etcetera, it's actually looking even earlier and says, what are your cells doing? What are they thinking of doing? Because that is going to determine your downstream health, right?
- 30:53Nailed it. So that's the bit that you're trying to really help people with, which I think people are hungry for, right? They want to understand their own physiology and we haven't even sort of come to the, how does that come into the whole mental health and fitness space?
- 31:08Brad: Oh my goodness.
- 31:09Nara: Because actually you want to tell people, this is where you are, but this is what you should do you And to a better I think there's a huge amount. So that's what there's a physicality and a physical health to it, but there's the mental health to it, and then the actual cardiovascular fitness as well. And the sports piece, obviously, which is where you started. You started as a sportsman, right? So that has to be a thread that goes through everything.
- 31:34Brad: A 100%. And I'll I'll I'll keep going with this, but there's something you said that's really important is the a lot people to make change
- 31:43Nara: Yeah.
- 31:43Brad: They need to understand why. And if you think about do
- 31:46Nara: you have children? Yes.
- 31:47Brad: Okay. When your kids are really young, I mean my kids are still doing this, but when you tell them something, you need to eat your vegetables, what do they say?
- 31:56Nara: Why? Right?
- 31:58Brad: That's a human element, right?
- 32:01Nara: Explain it to me. Why do I need to do that? Why do I need that? Why to do that? Yeah.
- 32:04Brad: So everybody knows they need to do exercise. Everybody's heard that. Yep. Why? Why?
- 32:12Nara: And it's hard, right?
- 32:13Brad: But if you can arm a story and make it personalized, we're more likely to do things. So the origin of what I'm trying to do is to answer whys so that the individual has so many answers to the why that it's kind of irrefutable. You've looked into Pandora's box. Do you really like, you have a emotional charge now.
- 32:34Nara: It's right here.
- 32:35Brad: You wanna do it or you don't want not to? Because you know why you do now instead of just like general advice.
- 32:40Nara: And so where does the fitness, how do you advise on that? How do you bring that thread in? And that's because, you know, some people really like doing one sport and would absolutely hate You doing another know, how do you say that to them? And it's very hard for people for whom sports and or fitness is not a big part of their life. Absolutely.
- 32:58You know, and even if it is, of course, there's twenty four hours in the day and everyone's really busy doing all sorts of things. How do you bring that fitness and sports element into that longevity piece or that sort of prevention piece?
- 33:10Brad: Yeah, so the key components that we're trying to establish the moment they walk in the door with us is that the major components of what drive health span and lifespan are number one, it's kind of irrefutable at this point, social connection. So connection with self and then those around you. So romantic, friendship, communal, and then work related. So we can't really help with that at Elevation.
- 33:37Nara: Other thing is But Do you verbalize it? Do you sort of say, you need to think about your
- 33:40Brad: You need to think about this.
- 33:41Nara: You need think about your relationships. We're not here to cancel you through it. Exactly.
- 33:44Brad: But that is the number one predictor of life longevity is social connections. And nothing that you do in your moonlight, your job as an ENT physician, nothing that I do with my work is going to directly affect that. But indirectly, the work that we do will help people have better connections with self and those around them by being in better health.
- 34:08Nara: Yep.
- 34:09Brad: So the other ones though are CNS improvement, so nervous system regulation, and then it's sleep, nutrition and movement. And the movement category of anaerobic and aerobic fitness are really important. They're dual portions of what movement is. Movement is medicine. And so we know just clinically speaking, sedentary life is one of the predictors of not a long life.
- 34:34Nara: Early death. Morbidity, yeah.
- 34:37Brad: Chronic disease acceleration. So when we help patients that come in with us and through our program, what we're trying to help them understand is that everything we're doing at Elevation is to amplify those other four things, is to make movement more understandable directionally, and then being able to do them more regularly because you're able to recover better, and your body's able to perform better over time because we're identifying key areas of limitation for those you know, areas. So back to, like, our our programs and what we're trying to build because you said something, the downstream effects of of cellular based aspects. So what what we're trying to interlink are, okay, all organ systems and how they're interconnected and how that plays a toll on someone over time. And so when we get these layers of viewpoints epigenetically and through blood work analysis that we're doing, we're still telling people it's not fully complete of what we would like to have because we're still missing elements of of signaling that can tell us stories and answer those whys.
- 35:48And so in our the reason why we started the company to begin with is our top program. Yep. And there's an investment to do it because it takes work to do it right. So in that program, what we're we're doing from the beginning is going all the way back in time. Okay.
- 36:03We're gonna do a whole genome sequence on you to have a full genomic profile on on how if you're born yesterday, what would your physiology crave from that moment? That builds a moat around you. I tell an example of like, here's your castle. Half of that moat is your genetic understanding. The other half is the epigenetic understanding because you weren't born yesterday.
- 36:28You're now 50 or 40 or 35 or 22.
- 36:32Nara: And things will have happened.
- 36:33Brad: And life has happened to you and with you, and you've chosen things. We don't put labels, but good, bad, indifferent, right? You've had an experience. You were one of one when you were born, but amplify that by no one's ever lived that life that you've lived ever before or will ever again. So that percentage on who you are and what has happened, you can't measure individuality.
- 36:59And so what we're trying to build that moat around and help understand is genetically, we're gonna bounce everything off of that. And then epigenetically, we're gonna bounce everything off of that so that we have a truer picture of who you are and what's going on with you and your physiology. And then we start layering in the origin area that we can analyze as much as possible today with science of what everything else leads to, which is the sell. So we have partnered with a company that's incredible. We've been with another one before, but we just signed a new partnership to bring to The UK and to The US, we'll be using as well, That our partner with MD Anderson, they've been working with large institutions.
- 37:41They just finished a giant study with traumatic brain injury at USF in The US. But they're looking at mitochondria in a way that helps understand the mitochondria profile and the outputs of mitochondria. I mean, we've trillions of mitochondria in our body, but the outputs of generally how your mitochondria is performing.
- 38:00Nara: Your mitochondria being the battery of your cell, which is where all the energy's made.
- 38:04Brad: Correct. We're everything and what we're learning so much is so interesting because I spent so much time in understanding genomic based cancer and how our genetics play that role into brecagines and all these things that could affect cancer later in life, but also how your lifestyle affects the expressive state of those genes as well. That whole area is extremely fascinating and continues to be for me. We We learned apply a
- 38:32Nara: lot a lot about that still. Tons. Yeah, we know a lot, but we're learning a lot.
- 38:35Brad: Still learning a lot. But what's even more evident, and we're learning more about this, is that there are subsets of cancer that are mitochondrial driven and how mitochondria play into that. And so what we do know that it affects cancer base, it affects neurodegeneration, Alzheimer's is directly related. We're learning that autism is even affected by mitochondrial dysfunctions. And so for us, our application, again, we're not trying to diagnose these things specifically, but what we're trying to uncover is dysfunction in mitochondria.
- 39:04If we can do that and understand why, again, more whys, then we can apply more strategies for you as an individual where you need to focus on for better cellular production. Ultimately ATP, this energy source is driving all of our systems in our body. Absolutely. And so we're trying to effect change even at the cellular level through this level of analysis as well. So we do stool testing as well every four months.
- 39:28We have a PhD on staff
- 39:31Nara: So it helps you understand microbiology, microbiome of the gut.
- 39:34Brad: Yep. We've got a PhD in genetics that is one of the best MSLs for epigenetics in the world, in my opinion. She's incredible. And then we have dieticians and doctorates in nutrition that are part of our staff that look at some of the profiling for genetics and how that applies to dietary elements and supplementation elements and things like that.
- 39:54Nara: There's quite a three sixty view here you're describing. Sorry, cut across your kick.
- 39:58Brad: No, but our quarterback of this whole thing, I use the American football analogy, I'm kind of You could say captain.
- 40:04Nara: Which is getting very big in The UK, by the way, the American football's taking off.
- 40:08Brad: Yeah. You could say captain of the UK football team is our clinical provider at the forefront. Yeah. That's bringing the specialist team together so that we can deliver not only a clinical approach to everything from hormonal management to thyroid care and all these clinical domains, but it then go into those functional domains that we feel are equally as appropriate for prevention and long term strategy of understanding cardiovascular risk just by being born and then current cardiovascular risk from detection as much as we're seeing. And then when you have that type of armed information, you can make daily habits of change.
- 40:48Then for someone to say, hey, you actually have to walk 13,000 steps a day. Why? They have This is their why. They have those strong whys too. It's not just like some vanity metric or just some, I don't really care.
- 41:02This is from a cardiovascular health. They also know that if they do two specific types of aerobic exercises where they're pushing their heart rate to certain realms for short amount of time, they're bringing a capacity to their system that's gonna affect other parts of their system that will put years on the end of their life. We can measure that based on them doing this for ninety and six months worth of this, how does this change your biology? We can see those things. And so we know that strength training, especially for women, also
- 41:34Nara: I was gonna ask you about that actually. So it's because I think we're starting to understand that we sort of thought, any exercise is exercise. And I think we're getting much more nuanced about that now. And appreciating that, there's the cardiorespiratory and high output sort of fitness things like sort of running, spinning, that sort of stuff. But to your point around the strength training, particularly in sort of older age groups is good at any age.
- 42:00But yes, so how do you again, I think being a sportsman yourself and understanding that very well, how do you sort of customize that? What sort of support do you give to people to say, this is why you should do this bit and this is why you should do that bit and this is how you do it? That's the other thing.
- 42:18Brad: Yeah, so we have some general guidelines. So we give out workout plans as part of their program.
- 42:24Nara: Oh, you do?
- 42:24Brad: Okay, We do, men and women. Are Can
- 42:27Nara: you customize that? So if somebody goes, actually, I hate this bit, but I really like that bit. Can you help me with that?
- 42:33Brad: We're launching that arm globally as a part of our UK launch too, to expand it to more kind of coaching elements for a one on one experience on fitness. I think it's needed. We've partnered with so many companies in the past and ultimately there's some great companies out there, but we wanna control in our ecosystem now moving forward because we have found people that are like, hey, I've got this injury, I need to adjust some things and things like that. We wanna be the ones taking aim of that. We've been so heavily focused on clinical nutrition and getting someone to build their pantry of what they should be doing.
- 43:06Nara: Yep.
- 43:06Brad: That it's affected so much change, but we are realizing, hey, we wanna be in control of the fitness element as well. So that's something that we're gonna be launching pretty soon. But we do give We have a fitness app and we have male and female programs, but we're gonna make them more customizable with our coaching that we'll be launching as well.
- 43:26Nara: Because where people are with the fitness, everybody sort of, we it's okay to sort of want to look good of course. But actually people are really saying, this is the body I have. This is the one body I have. You know, I've been gifted with it. It's got to last me for a while.
- 43:39And so you want it to do things and do those things really well. So there's flexibility in that, know, suppleness to your joints, your joints not wearing out, of course, as well as your heart and your lungs working well, and actually just having good muscle strength, good posture, and all of those things is a lot to think about.
- 43:55Brad: So much. We're not gonna ever claim to get into all those details. And it's why we have good referral, people that have postural or actual injuries, and they're working through things, we tend to recommend. We have a great network in The US. I'm gonna build out our network here as well for people that need more specialization into those movement patterns or things like that.
- 44:14And I'm speaking as like a patient myself, I need specific help that it's outside of our spectrum at elevation as well. But we do give guidance though on strategy. And so the strategy of how many days a week should I be strength training, male or female? What should I be focusing on? More women, I think, ever with the focus on longevity and health are opening up to strength training.
- 44:43Been shocked here in The UK how many women actually lift weights, legs. Yes. And it's awesome.
- 44:50Nara: Yes.
- 44:50Brad: So I'm very pleased with at least, you know
- 44:54Nara: Have you seen that as a difference? Big difference. Yeah.
- 44:56Brad: Interesting. A lot a lot of women don't tend to try to lift heavy. Yep. Pilates are great.
- 45:03Nara: Yep.
- 45:03Brad: Posture you just talked about posture. Pilates are great. I would never say not do Pilates. I think yoga can be beneficial like once or twice a week. But the majority of the focus should be building on capacity and resilience within your musculature system for multiple reasons.
- 45:23Male or female, but specifically females, building up density and bone mineral density with heavy leg training builds resilience into your bones where you're going to want that at seventy and
- 45:36Nara: eighty. 100%.
- 45:37Brad: It's also going to build a resilience and a musculature system that's going to be more cardio protective over time. It's interesting the more that we learn about how muscle mass regulates everything from metabolic disease, but also cardiovascular function and its ability to keep up with and protect the heart. There are so many aspects
- 45:58Nara: Muscle of to adipose tissue ratio and bulk, right? Yes. There's definitely, and we didn't really almost think that the muscle was an organ.
- 46:05Brad: Exactly. Now we're really
- 46:06Nara: understanding It's just taking tissue, yeah.
- 46:08Brad: Big time.
- 46:08Nara: And people sort of understanding that your bone, which is why obviously bone density loses if you go on an Artemis mission, which we're not about to do, but you don't care, is because of course there's no way the gravity is not there. It's actually your muscle pulling on your bone that encourages that muscle density to stay there. So if you're sedentary or if you're not doing that, particularly at a certain age, particularly for women, although it happens to everybody, you know, osteoporosis affects both genders. It's a thing that you have to actively work on.
- 46:37Brad: Have to. And what we tell people, and we try to make it as simple as possible, is three times the least minimum up to around, the sweet spot is usually about four times a week.
- 46:47Nara: And do you say how long? Is that what?
- 46:49Brad: Fifteen Forty five minutes.
- 46:50Nara: Forty five minutes
- 46:50Brad: to an hour. Mhmm. We have a structured way to do it. I mean, it it's all dependent on, you know, rest and recovery in between sets and then, you know, applying it strategically through the week. You don't wanna do all four days in a row, you want some recovery days, things like that.
- 47:04But mixing in your cardiovascular tolerance as well is really important. The huge difference in The UK versus The US is that just the nature of the landscapes. More people are walking in The UK. People walk around to commute through their life. In The US, no one walks.
- 47:27Nara: That's really interesting.
- 47:28Brad: It's very odd. They're walking with the intention of exercise in The US. We want
- 47:34Nara: to get places.
- 47:36Brad: In The UK are walking to it's part of societal life.
- 47:39Nara: Yeah.
- 47:40Brad: Which is great. We know just from population studies that The UK and most of Europe, the lifespan is longer on general population than The US right now. And it's not really hard to see why. It's the agricultural and dietary environment and then the societal norms of you walk, you're more active.
- 48:03Nara: And it's interesting, but it's also some which is a historical thing is how old a town or a city is. So you will see in The US, for example, a very old. So because you know that's how you got around, not everybody had a horse and cart, you literally had to walk to get from A to B, know, or if you had to go anywhere you kind of go on horseback before obviously motorized. So vehicles so it is whereas actually in The States particularly the younger towns and cities they are built with the intention of getting from A to B by a car it's a very interesting difference so you can walk miles on an average day if you're getting around London, for example.
- 48:43Brad: Yeah. And in The US, the world's gotten Not the world, but your societal life has gotten bigger over the years. So like back in the fifties, most people loved to commune around towns, which is very consistent with how I experienced The UK. But now more than ever, people are used to driving 40 miles all the time.
- 49:04Nara: Yes.
- 49:04Brad: And my friend lives way up here, so I drive. Yep. And so societal life is connected through that driving.
- 49:11Nara: Through that, yeah.
- 49:12Brad: So we have to kind of almost reinstill like, hey, normal life for you, if you want to live long, requires an amount of walking that you're just not gonna have as a societal norm. And so you have to think about it that way. Like intentionally, I'm changing how I view life to where can I walk? Can I walk there? Can I walk Do I need to default to walking, you know, driving to my sister's house who lives down the street Sleep?
- 49:38Nara: Yeah.
- 49:38Brad: When when I should just walk? Walk. Yeah. You know, that's something not normal
- 49:41Nara: And actually, walking beings are built Yes. Than running, by the way.
- 49:46Brad: Big time.
- 49:47Nara: You know? I agree. That's the that's the thing, that's why it's so good for you, that's kind of what your body's meant to do. It's built to do that.
- 49:54Brad: Big time. And, you know, normal things that can be prevented, men and blood pressure regulation, just walking after eating is a big deal. And a lot of men can naturally regulate with dietary changes and that type of lifestyle change, and regulate their blood pressure just through that one modality of walking. But for capacity and resilience, there needs to be back to the gravity conversation. There needs to be force, there needs to be an intentional charge on that.
- 50:29And so for cardiovascular, what would be generally speaking for health and longevity, you need to push yourself beyond just walking. And so we tend to say two thirty minute sessions a week with an intentional HIIT type style where you can push into certain zones and certain heart rates, you can get it done in two thirty minute sessions a week for cardiorespiratory capacity. That's just generally speaking for people. Then there are some psychos like myself who likes to push the
- 51:00Nara: envelope Do a lot more than that.
- 51:01Brad: More than that. And the other side of the fence, because everything's a bell curve, as a physician you understand this too. You know, on this side of the bell curve is sedentary. And then on this side of the curve is Tour de France, you know, crazy cardiovascular output. This is not healthy.
- 51:17You can't be a Tour de Franceman your whole life. You will die early, matter of factly speaking. And some of the best metabolic scientists, I'm fascinated about their research with mitochondrial health and metabolic health with these marathon runners even.
- 51:33Nara: Longevity Extreme sports is a very interesting
- 51:35Brad: Their longevity is not great. And so there's always a, okay, well where's the sweet spot? And so for some people like myself, it's usually saying dial it back a little bit. You need to dial it back. You need to recover because again, number two is CNS.
- 51:50And so how do we get your vagus nerve? How do get your sympathetic nervous system? How do you get this ability to recover over time like in a sweet spot? And a lot of that will come through diagnostics, but biometrics as well, we pull in that data. And so we can see.
- 52:08Nara: That's a very interesting piece actually, because that is one where if you went back before wearables, I remember a time when we were starting to get, it was basically the NHS was trying to sort of have a digital sort of arm where it actually connected all the different hospitals and shared information, etc. It actually didn't work at the time for reasons I won't go into, but it was one of those things that people just were not ready to share, even though it was anonymized, even though, you know, but they weren't ready to share their information and that's moved massively. And now we are very comfortable, in fact, encouraged for people to take agency and take control of their health. But it has meant that we, as a medical profession had to get better in understanding what that data meant.
- 52:53Brad: Sure.
- 52:53Nara: You know what I mean? Sure. So I'll give you an example that we don't understand hugely. So for example, heart rate variability.
- 52:58Brad: Oh yes, we could spend the
- 53:00Nara: whole time We spend on that. I think that's encouraged a better understanding from the medical profession around, well, what does that mean? And that's true for sleep, for example, and the zones, etcetera. And so it's opened up a whole conversation around, well, actually we've got a lot of data around it and we don't understand it really well.
- 53:23Brad: There's nuance. But if we're not talking about it, if we're not looking at it, we're doing ourselves and humanity a disservice. That's my opinion. That's why I'm so aggressive on the, you should be understanding as much as
- 53:35Nara: you can. And having that clarity, I think in some respects, those of us who either collect the data or curate the data or seek the data is to be really sort of transparent to say, look, we don't understand all this Fully, yeah. Yeah, can tell you what we do understand, but I think that comes with the humility of anything to do with human health is to go, you know, to try and pretend we understand. Just trying to understand it better all the time.
- 53:59Brad: Sure. Yeah. A 100% and heart rate variability, like, you know, people get obsessed with, okay, now that I have this thing, what does it mean exactly, like specifically? Yeah. But, you know, it's just good to look at it from a standpoint of just knowing what it is so that you can measure the influx if it's going down or up.
- 54:18Yep. Because generally speaking, you know that if your heart rate variability is going up, then you're doing a good job.
- 54:24Nara: Yep.
- 54:25Brad: That's great. Now, what does the five point jump Yep. Mean for Specifically, tell me exactly, you know, we don't fully know the answer to that but we know generally speaking what's gonna influence it. And if we can trend it that it's going up for you, not the number specifically but what it is.
- 54:41Nara: What the trend is doing. Then
- 54:43Brad: we're going in the right direction. And what's fascinating about sleep is I was so obsessed with at the beginning of man, everybody needed this much sleep. You have to get everybody to this top end and then women needed even more. So how do we do that? And I've gotten less rigid on that talking about nuance, of anecdotally all these patients that we've seen come through that improve sleep is the quality of the sleep made more of a difference for many of our patients.
- 55:15And so I'm more obsessed with maximizing quality of sleep and we have outliers just genetically that operate okay with five hours.
- 55:24Nara: Yes, yes.
- 55:25Brad: But if we can maximize those five hours of deep and REM sleep, that person's gonna have a net benefit.
- 55:32Nara: So And it's actually, and there is a whole overlap in the Venn diagram between the sleep, mental health as to where you are, as well as the activity overall. So for example, and you'll know this if you actually have a really heavy day of sort of, you know, like you've run a marathon or something, you will sleep like a baby. Because your body almost has that switch in a really sort of healthy way. So it's sort of from the sleep and trying to dovetail in the mental health piece as well, because that's a huge amount. Huge.
- 56:04Huge, huge piece, right?
- 56:06Brad: I think I read something the other day even that missing, I can't remember the exact amount of quality sleep. It was like smoking three packs of cigarettes of an equivalent when that happens. And so why it's such a powerful thing. But I mean, even thinking of it from a mental health aspect is our brain is like the one organ that takes a lot of damage unknowingly that we do to it. And sleep is one of those rejuvenation miracles that happens
- 56:40Nara: for You our really understand. You don't. You're very poorly.
- 56:42Brad: Really get all those details. I'm fascinated with I hate calling them bio hacks these days when I first started having these conversations years ago. I I loved that name, but it's kind of been hijacked into a Yes.
- 56:56Nara: A wooey Yes.
- 56:57Brad: Space, and so I removed that even label completely out. I I more like the the conversation around how can we manipulate biology in a positive manner.
- 57:08Nara: And modulate perhaps.
- 57:09Brad: And modulate. Yes. Yes, yeah, regulate, modulate. And what's interesting is like one modality and an intervention that we've seen, and there's more data coming out on this, is melatonin as a supplement has been either villainized or hero driven. And I've gone through this, I've been really resistant to melatonin.
- 57:36But what we're seeing, there's some interesting anecdotal studies, they're not cohort based randomized trials, is that in some people with massive fatigue, which we know correlate to affecting your brain.
- 57:53Nara: Yeah.
- 57:54Brad: Is when our circadian rhythm is not normalized and we don't have that natural melatonin production, for some people to do a mega dose for a couple days, this isn't, I need to explicitly say this is not medical device, so don't go do this. You should talk to a physician if this is a strategy you need to think about, do not take this and go home with it. But for some of these patients that have massive fatigue and their thyroid's now in check or their hormones are fine and they're still so fatigued they can't sleep, mega dosing for a couple days, some of these people, it's like turning on a light switch in the brain again and reset. And you don't continue on, it's not like you take melatonin every day, but there's some fascinating aspects of even how doing that can be a modulator to get back into a normalized circadian process. And then you have to behaviorally
- 58:44Nara: And do you talk do about sleep with your clients as well? All the time. All the time.
- 58:48Brad: Yes. And looking at it.
- 58:49Nara: Do you, because one of the things I think is very poorly understood still is the thing that we spend most of our life doing in fact, not quite as much as awake, but nearly. One of the emerging theories is that during that time, there's almost like a sort of like a filtering of all the pro inflammatory potentially harmful compounds. And it'll just allows the brain to sort of almost reset to some degree, which is why if you're having very poor quality sleep for whatever reason, those don't happen. And there is a link with poor quality sleepinsomnia, well as neurodegenerative conditions. Now which was the chicken, which one's the egg?
- 59:29We don't know. But there's a huge piece around that. So how do you help your clients in that to sort of try do that better? Because it's also like the more you try and get a better quality sleep, the more it sleeps through your fingers in some respects, trying to, so how do you help them through that?
- 59:47Brad: Big time. And again, this is a little bit of hypothesized theory here, but even the example that I'm giving with the melatonin, what we're coming to understand with this a little bit is that it's kind of like an antioxidant for
- 1:00:02Nara: the brain.
- 1:00:02Brad: But as you know, if I were to take an overload of antioxidants every day, it's a positive thing for the body, right? Antioxidants. But if I were to overdose antioxidants all day, every day, it hermetically would not be beneficial and my homeostasis would be completely out, like driven offline. And then there'd be problems. I'd probably be majorly fatigued because of that.
- 1:00:25And so that's what's interesting about it is with sleep is that some of these interventions, if they're short term RAN can be very beneficial, almost like a brain antioxidant. But there's a whole, I have my personal, we're not gonna do it in elevation, I've gotta put a disclaimer here until it was ever legalized. But there's a whole subset of brain healing that's finally getting the recognition that it should, which is in the psychedelic
- 1:00:55Nara: realm. The psychedelic, yeah, yeah.
- 1:00:57Brad: And the FDA just had a major announcement a couple of weeks ago in The US. I have some good friends that run FDA regulated centers. And I've seen major work that they do with people with major traumatic brain injury, PTSD, veterans, people like that. But if you're someone that carries heavy trauma and you can't break it, and you've gone through the psychiatric rounds, you've gone through the psychologist rounds, and you're just constantly in fight or flight, I mean, that's clinically what's happened, their nervous system is just always shot, their brain is gonna be affected.
- 1:01:34Nara: 100%.
- 1:01:35Brad: Now again, we don't have all those answers, but what we have seen is that if you can, with these psychedelics, the research that's coming out is the right left brain hemisphere communication and some of these things that they've studied is a net positive for a lot of these subset groups. Now this isn't blanket advice for everybody to go and do this recreationally, but even these channels are opening up areas of clinical medicine that I'm so
- 1:02:06Nara: It's new.
- 1:02:07Brad: I'm so happy, it's new. I know King's College in London is doing some great work and similar kind of research with this, but brain health alone is one of those key areas because it's the control, the starting point of everything else.
- 1:02:21Nara: We know so little actually about the brain. We know more about the cosmos than the other part of the brain, which is, but we're getting there. I think there is a huge, for years, particularly life sciences, biocide, it's been a sort of the Cinderella research, neurodegenerative conditions, dementias, etcetera. But now there are definite pushes and interest to sort of understand it better, treatment modalities, etcetera. Even if they are shifting the needle a little bit, they did do that.
- 1:02:51I'm gonna ask you about one of the really interesting things that you said is around nutrition, which is one of the things that will feed into pretty much everything, right? And the GLP-one, not necessarily to go down that route per se, but just to say, where does the whole nutrition piece sit for you as a sportsman, as well as obviously running a company that focuses on that overall holistic health? Because people will come to you and say, okay, I've got the exercise down, I'm doing what sleep should I eat? Bearing in mind, there's a huge amount out there and people don't know that should I be doing more of this or less of that? Where does the omegas fit in and where does fats fit in?
- 1:03:29Do I have to go vegan? How do you guide them through that labyrinthine advice?
- 1:03:36Brad: Yeah, we're taking So there's two approaches to nutrition from my perspective. And elevation is heavily focused currently on one side. And then again, we're gonna open up our coaching element for the global expansion soon, which will be on the other. And most have been focused on this other side. There's the performance side and then there's the clinical side.
- 1:04:00And our focus has always been on the clinical side. And what do I mean by that? What are the things that for you as an individual, should you be aware of to build good metabolic flexibility, but also as a unique pantry for you? Everybody, if you go online on social media these days, we talked a lot about this a little bit before, you can get inundated with a ton of information.
- 1:04:24Nara: And that's the problem, and you don't know what you should listen to.
- 1:04:27Brad: And if you type in what diet is best in social media, I mean, you can go do this experiment. Just start swiping through. Do you think there'll be anything that's consensus? Absolutely not.
- 1:04:39Nara: So if we loop back to that piece we're talking about around that holistic approach to how you look after individuals, obviously helping them understand the epigenetics, etcetera, And there's a whole piece around the nutrition. Where do you feel that sits in with what you're trying to do for your clients and with the whole holistic approach to their wellness?
- 1:04:59Brad: Yeah, so there's two components that we're trying to analyze from to help individuals actually progress. And the first part is the clinical domain. The other part is performance and that's a little bit different. That's a little bit around kind of more specific goals and kind of vanity metrics of physiology. But the clinical side is more like what is the long distance plan on what I should be doing?
- 1:05:22And so the way that we kind of describe it is building an individualized pantry, if you will. So your pantry could be different than mine. What we're trying to do is build metabolic flexibility. Again, if you scroll through social media and you said, what is the best diet? You'd see a ketogenic diet, you'd the carnivore based diet, an omnivore, plant based, and you'd have competing people, clinical folks, or fitness folks, or whomever with the reason why this diet is better for everybody.
- 1:05:51Nara: And very convincing reasons.
- 1:05:53Brad: Very convincing too. And every day it's something new of why theirs is better than the other one. What tends to be more just safe is that, like an omnivore diet has done really well. Yes, For it's almost every pretty single person, because we're still here. And we know with that, that those particular elements of an omnivore diet play a net positive on the physiology.
- 1:06:21But it's within that omnivore diet, how do we build a pantry for an individual that's unique? And so when we get into the clinical domains of where the risks are, that will play a part of the pantry build out. When we go into the genetic realms, this is what's really interesting that we do that's unique. We can actually see genetically how those chemical processes in the body get broken down and where some possible deficiencies could be. Does this mean that they have an autoimmune disease?
- 1:06:52Absolutely not. But what we do know is that if compounding interest plays in into this in some capacity, that if you're if you're putting in a less efficient deposit over and over and over again, it's probably not gonna have as great
- 1:07:07Nara: The overtone of a
- 1:07:08Brad: return Yep. Than putting the thing that's more conducive to you. So I always use the example, do I think saturated fat is bad? No. But it can be for some people.
- 1:07:18Nara: Yes.
- 1:07:19Brad: And so for me specifically, when we break down the category of fats and we get into omega indexes and we get into linoleic acid and oleic acid and saturated fat, polyunsac we break those all down, we can actually see just in that category of fats where less efficiency lies. So for me, I have a higher response to saturated fat. So if I'm a person that has a cardiovascular risk, a genetic inefficiency, I have epigenetic things that are showing me that my cardiovascular nature and inflammatory load is higher, then I'm probably not having the best strategy by having everything cooked in butter and ghee in my pantry.
- 1:07:59Nara: So
- 1:08:01Brad: we help build that pantry for people in what their 90% should look like. So that most of the time is an omnivorous type diet, but there are people that do better in lower carbohydrate ranges. There are people that do better with somewhat of a higher fat range. And then with protein intake, we're trying to match basically your weight in kilograms or pounds up or down based off of some goals. And if we need to lose weight, if we need you to maintain, if we need you to build muscle, that all kind of manipulates a little bit.
- 1:08:34So that's the pantry realm that we're looking at, but we heavily rely on the data to build that for.
- 1:08:39Nara: And I really like your 90% accepting that
- 1:08:42Brad: We're all gonna eat ice cream and cake and we're all gonna have a beer every once in while. But if you're doing that every day, not a
- 1:08:50Nara: great strategy
- 1:08:51Brad: for anyone.
- 1:08:52Nara: But actually that's accepting the human nature of it all, So going back to right where we started, or actually I will ask you first, where do you what's the vision for Elevation? Where are you going? Where do you want it to go? And what's the vision that you're trying to deliver?
- 1:09:11Brad: I love this question. It's to create the environment in the marketplace of what I felt like traditional medicine on the preventative side should be, have been focused on for the last thirty years. So all of our partnerships, we're trying to create an environment where when they come to us, you feel like you're in charge of where your direction is on your own health. You're relying on us to be your brokers of everything from a preventative standpoint of who are the best analytics in this capacity or that capacity? Like we have partnerships with Clearly AI in The US.
- 1:09:49We just signed a partnership this last month with Ezra in The US to do full body MRI. So we have all these partnerships. We're gonna continue to keep evolving what that looks like for our patients and then give them access to the things that we feel like are gonna be the best tools in the toolbox to prolong and improve current lifespan. But that all comes down to as science evolves, we will be ready. And so our environment has to ready
- 1:10:13Nara: So very on pivot the front foot to sort of change and pivot as the evidence changes and pivot, right? Constantly. And then last question to ask you. So it was really interesting at right where we started, you were sort of telling me about, you know, whence you came and sports and sportsmanship and prevention and overall holistic health is clearly deeply ingrained in all that you're trying to do. How do you feel all of those early experiences have shaped you?
- 1:10:37And the dovetail conversation into that is how do you think that's fed into your leadership style and how you are steering evolution, elevation rather through to its success?
- 1:10:51Brad: Yeah, so nothing is concrete. That's the one thing that I absolutely know. And if you are hyper curious on figuring out what's best now and not rigid to where that could be different in the future, you're more susceptible to having good longevity even in your career or just your own life. That curiosity feeds the ability to evolve. And so for my leadership style, it's constantly is we may do this way right now because it's the best based off of all the data points that we have, the feedback that we have.
- 1:11:34But next week, something might come out revolutionary that may be completely transformative to these three things that we thought. And that happens a lot. My leadership style is to take my team to keep thinking like that and be ready. It's not if it's happening, it's when. It's when new things come in, are they ready to be able to adapt that in for our patients and patient population as well.
- 1:12:01So I have a call later in two hours for something that's pretty revolutionary to see how that would fold into our workflow globally. So there are things that are constantly evolving and where I want this to be. But the curiosity is what drives me constantly. It's what I want my team to think through and our patients
- 1:12:21Nara: to Yeah, think you're sort of looking at that sort of holistic true health in a three sixty way, right?
- 1:12:27Brad: Yes, constantly.
- 1:12:28Nara: Wonderful. Thank you, Brad.
- 1:12:30Brad: Yeah. Thank for your wonderful.
- 1:12:32Nara: Really love that. Thank so much.
- 1:12:33Brad: Thank you
- 1:12:33Nara: for the time.
- 1:12:34Brad: Thank you.